Currently, China's stem cell industry has entered a new stage of development. A series of stem cell support policies recently introduced by the national government and various provinces and cities clearly demonstrate the growing emphasis on clinical research and translational applications of stem cells, creating a favorable policy environment that is propelling the rapid expansion of the industry. Meanwhile, an increasing number of companies are already sensing the immense business opportunities inherent in the stem cell sector, prompting them to strategically position themselves and seize these emerging industry prospects.

As the stem-cell innovation division under Jiuzhitang Group, Jiuzhitang Maker has consistently drawn significant attention from industry insiders. After several years of growth, what does Jiuzhitang Maker look like today? Here are a few recent highlights and major developments at Jiuzhitang Maker!

Jiuzhitang Maker Successfully Selected for Beijing's "Specialized, Fine, and New" Enterprise List

According to Beijing's eligibility criteria, companies selected as "Specialized, Fine, and New" enterprises must achieve industry-leading performance in key areas such as economic efficiency, degree of specialization, innovation capability, and operational management—and are poised to become either internationally recognized industry single champions or hidden champions in the future.

Jiuzhitang Maker has once again passed the "National High-Tech Enterprise Certification."

The National High-Tech Enterprise designation is jointly recognized by three government departments: the Ministry of Science and Technology, the Ministry of Finance, and the State Administration of Taxation. It involves a comprehensive, all-around evaluation of companies, with exceptionally high qualification thresholds, stringent standards, and a lengthy approval process. Companies must undergo multiple rounds of rigorous screening, meticulous review, and public disclosure—making this one of the most prestigious accolades for China's high-tech enterprises.

Jiuzhitang Maker has once again been listed as a "Beijing-based SME with High Technology Content."

Beijing's science and technology-based SMEs are small to medium-sized enterprises that rely on a certain number of science and technology professionals to engage in research and development activities, secure independent intellectual property rights, and transform these into high-tech products or services—thereby achieving sustainable growth. These SMEs are characterized by their high technological content and strong innovation capabilities, making them dynamic and highly promising players in the innovation ecosystem—and they serve as the key driving force behind the cultivation and development of new growth engines.

Only by producing higher-quality stem cells can we develop better stem-cell-based medicines.

Since its establishment in 2018, Jiuzhitang Maker has remained steadfastly focused on stem cell-based drug development and clinical translation, maintaining a rapid growth trajectory. The company has continuously strengthened its internal capabilities by refining its processes and workflows, while also introducing cutting-edge, internationally advanced stem cell expansion technologies—and consistently upgrading these processes to overcome key technical challenges, such as residual bovine serum. With a strong emphasis on building and managing a robust quality system, Jiuzhitang Maker has established a comprehensive, end-to-end framework spanning the entire stem cell industry chain, encompassing process development, manufacturing, and quality control. This robust infrastructure now serves as a powerful driving force behind the company’s commitment to stem cell pharmaceuticals and CQDMO services in the stem cell sector.

Meanwhile, Jiuzhitang Maker has also partnered with several renowned Grade-III hospitals across China to accelerate the development of multiple pipeline products. Driven by a combination of management strengths, cultural alignment, and team resilience, Jiuzhitang Maker has successfully built its robust, differentiated core competitive advantage.

Today, Jiuzhitang Maker has received full recognition and high praise from China's authoritative national agencies in areas such as core technology for stem cell products, its ability to commercialize scientific and technological achievements, independent intellectual property rights, corporate growth metrics, stem cell drug development capabilities, organizational management excellence, and talent structure.

"Though no one sees the craftsmanship, heaven knows the sincerity behind it." The ancestral teachings of Jiuzhitang, a brand with over 370 years of history, still resonate deeply. For more than three centuries, Jiuzhitang has maintained rigorous control over product quality—a testament to the company's unwavering commitment and dedication to excellence. Looking ahead, Jiuzhitang Maker will continue to embrace a long-term vision, diligently strengthening its internal capabilities while steadily advancing the high-quality development of its stem-cell pharmaceutical enterprise.